FibroBiologics Ownership | Who Owns FibroBiologics?
FibroBiologics Ownership Summary
FibroBiologics is owned by 5.17% institutional investors, 17.85% insiders, and 76.98% retail investors. Vanguard group is the largest institutional shareholder, holding 2.82% of FBLG shares.
FBLG Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | FibroBiologics | 5.17% | 17.85% | 76.98% |
| Sector | Healthcare Stocks | 35.49% | 11.75% | 52.76% |
| Industry | Biotech Stocks | 34.83% | 11.71% | 53.46% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 1.22M | 2.82% | $273.68K |
| Luminus management | 26.63K | 0.07% | $345.77K |
| Newedge advisors | 16.91K | 0.04% | $9.23K |
| Royal bank of canada | 2.01K | 0.01% | $1.00K |
| Fmr | 1.20K | 0.00% | $655.00 |
| Renaissance | - | - | - |
| Drw securities | - | - | - |
| Wiley bros.-aintree capital | - | - | - |
| Point72 asset management | - | - | - |
| Legal & general group | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Luminus management | 26.63K | 0.31% | $345.77K |
| Wiley bros.-aintree capital | - | - | - |
| Marshall wace, llp | - | - | - |
| Legal & general group | - | - | - |
| Drw securities | - | - | - |
| Renaissance | - | - | - |
| Cerity partners | - | - | - |
| Strs ohio | - | - | - |
| Point72 asset management | - | - | - |
| Geode capital management | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Luminus management | 26.63K | 0.31% | 26.63K |
| Royal bank of canada | 2.01K | - | 114.00 |
| Barclays | - | - | -1.00 |
| Ifp advisors | - | - | -2.00 |
| Srs capital advisors | - | - | -2.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Yorkville advisors global, lp | - | - | -509.79K |
| Blackrock funding, inc. /de | - | - | -482.40K |
| Landscape capital management | - | - | -350.00K |
| Geode capital management | - | - | -348.76K |
| Cascade financial partners | - | - | -314.58K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Luminus management | 26.63K | 0.31% | 26.63K | $345.77K |
Sold Out
| Holder | Change |
|---|---|
| Barclays | -1.00 |
| Srs capital advisors | -2.00 |
| Ifp advisors | -2.00 |
| True wealth design | -10.00 |
| Morgan stanley | -13.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 16 | -69.81% | 2,224,719 | -58.43% | 5 | 2.69% | 4 | -80.95% | 1 | -93.75% |
| Sep 30, 2025 | 18 | -66.04% | 2,042,975 | -56.57% | 5 | 3.57% | 6 | -76.00% | 4 | -71.43% |
| Jun 30, 2025 | 56 | -13.85% | 5,105,357 | -20.53% | 13 | 4.31% | 27 | -18.18% | 16 | 33.33% |
| Mar 31, 2025 | 64 | 4.92% | 6,419,503 | 19.66% | 17 | 6.83% | 32 | 6.67% | 12 | 20.00% |
| Dec 31, 2024 | 62 | 5.08% | 5,939,365 | 8.81% | 17 | 6.68% | 31 | -11.43% | 10 | 66.67% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 04, 2026 | Khoja Hamid | Chief Scientific Officer | Buy | $11.40K |
| Mar 04, 2026 | O'HEERON PETE | CHIEF EXECUTIVE OFFICER | Buy | $6.01K |
| Mar 03, 2026 | O'HEERON PETE | CHIEF EXECUTIVE OFFICER | Buy | $7.37K |
| Mar 02, 2026 | O'HEERON PETE | CHIEF EXECUTIVE OFFICER | Buy | $6.15K |
| Mar 02, 2026 | Davis Jason | Chief Financial Officer | Buy | $28.97K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | 6 | - |
| 2025 Q4 | 1 | - |
| 2025 Q2 | 1 | - |
| 2025 Q1 | - | - |
FBLG Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools